PATENT CLAIM ANALYSIS

Application Number: 16030410
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["546", "290000"]

Abstract:
2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid is useful in the modulation of blood or serum uric acid levels. In some embodiments, 2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid is used in the treatment or prevention of disorders related to aberrant levels of uric acid. In some embodiments, 2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid is used for reducing serum uric acid levels in a human. Also described herein are compositions comprising 2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid, and their use in the modulation of blood or serum uric acid levels.

Claim (Index 46):
A pharmaceutical composition comprising between about 2 mg and less than 10 mg of 2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 95.0
- Lexical Diversity: 2.73333
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14355480', '12324764', '13174568', '13704192', '12560113']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7973990759715824
- 35 USC 102 Novelty (BERT): 0.6849948019189754
- Combined Prediction Score: 0.7861586485663218
- Mean Citation Score: 463.49223
- Max Citation Score: 841.9516
- Similarity Product: 675.8170709971666

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test